HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy
Titel:
HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy
Auteur:
Sonneveld, Milan J. Chiu, Shao-Ming Park, Jun Yong Brakenhoff, Sylvia M. Kaewdech, Apichat Seto, Wai-Kay Tanaka, Yasuhito Carey, Ivana Papatheodoridi, Margarita Colombatto, Piero van Bömmel, Florian Janssen, Harry L. Berg, Thomas Zoulim, Fabien Ahn, Sang Hoon Dalekos, George N. Erler, Nicole S. Brunetto, Maurizia Wedemeyer, Heiner Cornberg, Markus Yuen, Man-Fung Agarwal, Kosh Boonstra, Andre Buti, Maria Piratvisuth, Teerha Papatheodoridis, George Chen, Chien-Hung Maasoumy, Benjamin